pyronaridine has been researched along with artesunic acid in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.33) | 18.7374 |
1990's | 4 (9.30) | 18.2507 |
2000's | 10 (23.26) | 29.6817 |
2010's | 22 (51.16) | 24.3611 |
2020's | 6 (13.95) | 2.80 |
Authors | Studies |
---|---|
Cao, DQ; Dong, Y; He, H; Liu, DQ; Liu, RJ; Yang, HL; Yang, PF; Zhang, CY | 1 |
Huang, WJ; Li, J | 1 |
Dong, Y; Liu, D; Liu, R; Yang, H; Yang, P; Zhang, B; Zhang, C | 1 |
Dong, Y; Huang, KG; Liao, MZ; Liu, DQ; Yang, HL; Yang, PF; Yang, YM; Zhang, CY | 1 |
Ambroise-Thomas, P | 1 |
Fan, B; Huang, Z; Ma, X; Wen, Y; Yang, J; Yang, Z; Zhao, W | 1 |
Gao, BH; Huang, KG; Yang, HL | 2 |
Gao, BL; Yang, HL | 1 |
Jomaa, H; Ortmann, R; Schlitzer, M; Wiesner, J | 1 |
Feng, XP; Liu, DQ | 1 |
Bongard, E; Croft, SL; Peters, W; Rattray, L; Robinson, BL; Stewart, L; Vivas, L | 1 |
Bélard, S; Cisse, B; Fleckenstein, L; Glasenapp, Iv; Issifou, S; Kammer, J; Koumba, PK; Kremsner, PG; Kurth, F; Lell, B; Mordmüller, B; Nemeth, J; Oeuvray, C; Ramharter, M; Schlie, M; Schreier, AC | 1 |
Bélard, S; Kremsner, PG; Kurth, F; Mordmüller, B; Pongratz, P; Ramharter, M | 1 |
Craft, JC; Fleckenstein, L; Jang, IJ; Kirsch, LE; Naik, H; Shin, CS; Tan, B; Yu, KS | 1 |
Nosten, FH | 1 |
Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
Nau, JY | 1 |
Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Poravuth, Y; Purnama, A; Pyae Phyo, A; Rao, BH; Rueangweerayut, R; Shin, CS; Socheat, D; Tjitra, E; Uthaisin, C; Valecha, N | 1 |
Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Jung, D; Lopez-Lazaro, L; Methaneethorn, J; Morris, CA; Pokorny, R; Shin, CS | 1 |
Abdulla, S; Binh, TQ; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Pénali, LK; Phyo, AP; Poravuth, Y; Rueangweerayut, R; Shin, CS; Tien, NT; Tinto, H; Uthaisin, C; Valecha, N | 1 |
Holtermann, MK | 1 |
Bhatt, KM; Borghini-Fuhrer, I; Bustos, MD; de Salazar, PM; Doumbo, OK; Duparc, S; Fleckenstein, L; Kayentao, K; Kimani, J; Kokolomami, JH; Offianan, AT; Ouédraogo, A; Pénali, LK; Quicho, F; Ramharter, M; Shin, CS; Tiono, AB; Tshefu, AK | 1 |
Arbe-Barnes, S; Borghini-Fuhrer, I; Craft, CJ; Duparc, S; Fleckenstein, L; Miller, RM; Shin, CS | 1 |
Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
Arbe-Barnes, S; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Lopez-Lazaro, L; Miller, RM; Morris, CA; Pokorny, R; Shin, JS | 1 |
Ashley, EA; Blessborn, D; Chairat, K; Day, NP; Hanboonkunupakarn, B; Jittamala, P; Lee, SJ; Nosten, F; Panapipat, S; Pukrittayakamee, S; Tarning, J; Thana, P; White, NJ | 1 |
Beavogui, AH; Bjorkman, A; Borghini-Fuhrer, I; Borrmann, S; Camara, D; Compaore, YD; Coulibaly, AS; Dara, N; Diallo, MS; Dicko, A; Djimdé, AA; Doumbo, OK; Duparc, S; Fofana, B; Gil, JP; Kabore, MJ; Miller, RM; Nikiema, F; Ouedraogo, JB; Sagara, I; Shin, J; Sirima, SB; Somé, AF; Soulama, I; Sylla, MM; Thera, I; Traore, OB; Zongo, I | 1 |
Ayyoub, A; Borghini-Fuhrer, I; Djimde, AA; Duparc, S; Fleckenstein, L; Methaneethorn, J; Ramharter, M; Shin, JS; Tekete, M | 1 |
Borghini Fuhrer, I; Canavati, SE; Denis, MB; Dondorp, AM; Duparc, S; Heng, P; Huy, R; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Tol, B; Vestergaard, LS | 1 |
Amalvict, R; Benoit, N; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
Choy, F; Makio, N; Mens, P; Okach, S; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
Bousema, T; Bradley, J; Makio, N; Mens, PF; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
Hine, P; Pryce, J | 1 |
Fidock, DA; Okombo, J | 1 |
Bustos, MD; Cong Tran, D; Hong Huynh, Q; Khim, N; Quang Bui, P; Quang Nguyen, T; Ringwald, P; Thanh Le, D; Thanh Tran, D; Thi Ta, T; Van Truong, H; Witkowski, B | 1 |
Augustin, Y; Kamarulzaman, A; Kremsner, P; Krishna, S; Platteeuw, H; Sall, A; Staines, HM; Wang, J; Xu, C | 1 |
Bailly, C | 1 |
Held, J; Hoffmann, W; Koehne, E; Kreidenweiss, A; Kremsner, PG; Mombo-Ngoma, G; Ramharter, M; Rodi, M; Zander, N; Zoleko-Manego, R | 1 |
Tsanni, A | 1 |
6 review(s) available for pyronaridine and artesunic acid
Article | Year |
---|---|
[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthyridines; Plasmodium; Sesquiterpenes | 2000 |
New antimalarial drugs.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Design; Drug Resistance; Ethanolamines; Flavonoids; Fluorenes; Fosfomycin; Global Health; Humans; Lumefantrine; Malaria; Naphthoquinones; Naphthyridines; Plasmodium falciparum; Proguanil; Sesquiterpenes | 2003 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2019 |
Repurposing Antimalarials to Tackle the COVID-19 Pandemic.
Topics: Antimalarials; Antiviral Agents; Artemisinins; Artesunate; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Drug Repositioning; Humans; Naphthyridines; SARS-CoV-2 | 2021 |
Pyronaridine: An update of its pharmacological activities and mechanisms of action.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum | 2021 |
14 trial(s) available for pyronaridine and artesunic acid
Article | Year |
---|---|
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, Liquid; Eating; Female; Humans; Male; Mass Spectrometry; Models, Statistical; Naphthyridines; Plasma; Republic of Korea; Young Adult | 2009 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Time Factors; Treatment Outcome; Young Adult | 2011 |
Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Male; Middle Aged; Naphthyridines; Ritonavir; Young Adult | 2012 |
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthyridines; Proportional Hazards Models; Young Adult | 2012 |
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dosage Forms; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasite Load; Recurrence; Tablets; Treatment Outcome | 2012 |
Pharmacokinetic interaction between pyronaridine-artesunate and metoprolol.
Topics: Adolescent; Adult; Alanine Transaminase; Antimalarials; Artemisinins; Artesunate; Aspartate Aminotransferases; Female; Humans; Male; Metoprolol; Middle Aged; Naphthyridines; Young Adult | 2014 |
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Primaquine; Thailand; Young Adult | 2015 |
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child; Child, Preschool; Drug Combinations; Female; Guinea; Humans; Infant; Malaria; Male; Mali; Middle Aged; Naphthyridines; Plasmodium; Retreatment; Treatment Outcome; Young Adult | 2016 |
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Topics: Adolescent; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Models, Theoretical; Naphthyridines | 2015 |
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Longitudinal Studies; Malaria; Male; Naphthyridines; Quinolines; Young Adult | 2018 |
Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines | 2018 |
Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Reverse Transcriptase Polymerase Chain Reaction; Self-Sustained Sequence Replication | 2018 |
Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Prospective Studies; Vietnam | 2020 |
23 other study(ies) available for pyronaridine and artesunic acid
Article | Year |
---|---|
[Sensitivity in vitro of Plasmodium falciparum to chloroquine, pyronaridine, artesunate and piperaquine in south Yunnan].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1992 |
[Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1988 |
[Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Humans; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1995 |
In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; China; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; Laos; Microbial Sensitivity Tests; Myanmar; Naphthyridines; Plasmodium falciparum; Quinine; Sesquiterpenes | 1997 |
[In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1998 |
[Effect of pyronaridine, mefloquine and quinine on artesunate-sensitive and artesunate-resistant Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Synergism; Mefloquine; Naphthyridines; Plasmodium falciparum; Quinine; Sesquiterpenes | 2000 |
[In vitro response of Plasmodium falciparum FCC1/HN to artesunate, pyronaridine and other antimalarials].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Naphthyridines; Plasmodium falciparum; Sesquiterpenes | 2002 |
[Monitoring of sensitivity of artesunate-resistant Plasmodium falciparum to pyronaridine].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Naphthyridines; Plasmodium falciparum; Sesquiterpenes | 2000 |
[Factors affecting the in vitro microtest for drug sensitivity of Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood; Chloroquine; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2003 |
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; In Vitro Techniques; Inhibitory Concentration 50; Malaria; Mice; Naphthyridines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2008 |
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Gabon; Humans; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Polymerase Chain Reaction; Safety; Treatment Outcome | 2008 |
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
Topics: Administration, Oral; Adolescent; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Biological Assay; Child; Child, Preschool; Chloroquine; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinine; Regression Analysis | 2009 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
[A new antimalarial drug combination].
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Treatment Outcome | 2010 |
[New combination therapy against malaria].
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug Combinations; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Mefloquine; Naphthyridines | 2012 |
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2013 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Young Adult | 2016 |
Absence of Association between Polymorphisms in the RING E3 Ubiquitin Protein Ligase Gene and Ex Vivo Susceptibility to Conventional Antimalarial Drugs in Plasmodium falciparum Isolates from Dakar, Senegal.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Lumefantrine; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Quinine; Quinolines; Senegal; Ubiquitin-Protein Ligases | 2016 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Pyronaridine-artesunate Shows Promise as an Effective and Well-tolerated Treatment for Artemisinin-resistant Plasmodium falciparum Malaria.
Topics: Artemisinins; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Vietnam | 2020 |
Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Artesunate; Child; Drug Combinations; Gabon; Humans; Larva; Methylene Blue; Mice; Naphthyridines; Schistosoma haematobium; Schistosoma mansoni; Schistosomiasis haematobia; Schistosomiasis mansoni | 2021 |
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |